|
⚲
|
| Keyboard |
| Langecker Peter
✚
|
|
|---|---|
| CIK # | 0001282829 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001282829] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Mateon Therapeutics Inc | |
| Langecker Peter |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Mateon Therapeutics Inc OXGN
Common Stock, $0.01 par value per share
|
2013-08-08 | Grant | 72,993 | $0.00 | |
|
Mateon Therapeutics Inc OXGN
Common Stock, par value $0.01 per share
|
2013-06-28 | Buy | 3,000 | $2.75 | 8,250 |
|
Mateon Therapeutics Inc OXGN
Common Stock, par value $0.01 per share
|
2013-06-25 | Buy | 2,000 | $2.79 | 5,580 |
|
Mateon Therapeutics Inc OXGN
Stock Option (Right to Buy) · derivative
|
2013-02-27 | Grant | 8,333 | $0.00 | |
|
Mateon Therapeutics Inc OXGN
Stock Option (Right to Buy) · derivative
|
2012-07-30 | Grant | 100,000 | $0.00 |